The number of horses and birds with clinical signs of encephalitis has increased in the past 4 years because of the emergence of the West Nile (WN) virus in the Western hemisphere. By the end of year 2001, the WN virus was identified in most states in the eastern half of the United States. The eastern equine encephalomyelitis (EEE) virus is endemic in the same region. Nearly 800 equine clinical cases of either EEE or WN were identified by testing conducted at the National Veterinary Services Laboratories (NVSL), From the USDA Animal and Plant Health Inspection Service, Veterinary Services, National Veterinary Services Laboratories, Ames, IA 50010 (Johnson, Ostlund, Schmitt) .
Ames, Iowa, in 2001. In 2002, nearly 15,000 equine clinical cases of EEE or WN were diagnosed nationally. Animal exposure to either disease can be determined by serological testing performed on acute-phase serum or cerebrospinal fluid (CSF). An equine immunoglobulin M-capture enzyme-linked immunosorbent assay (MAC-ELISA) specific for either EEE or WN supports recent exposure of equids to either disease. 4, 6 Viral infection can be confirmed by isolation of virus from animal tissues; virus isolation testing can require 3 weeks. Alternatively, the presence of viral nucleic acid can be determined by reverse transcription-polymerase chain reaction (RT-PCR) testing in one day. Because EEE and WN are zoonotic infections and important equine pathogens, rapid determination and identification of a viral agent are important. To expedite diagnosis, a nested multiplex RT-PCR (mRT-PCR) was developed that is capable of simultaneously detecting and differentiating the WN virus and the EEE virus directly from horse tissue and tissues of other mammalian and avian species.
The nested mRT-PCR was designed to incorporate previously described WN-specific primers 3 with EEE primers having similar cycling parameters. The WN primers amplified a portion of the conserved envelope region of the genome of WN virus NY99 (GenBank accession number AF196835). Computer software a was used to design EEE-specific primers. The selected EEE primers amplified a portion of the envelope region (E2) of the genome of North American EEE virus (GenBank U01034). This region was compared with numerous other North American EEE virus isolates collected over 60 years (GenBank) and found to be highly conserved. First-stage primer sequences, amplifying a 565-base pair (bp) region, were EEE-9233: 5Ј-AGGGCTTACCTGATTGAC-3Ј and EEE-9797c: 5Ј-GTAACGCCAGGAGTATTG-3Ј. Nested primers amplifying a 140-bp region were EEE-9571: 5Ј-GGC TCAAGAGTCAGGAGA-3Ј and EEE-9710c: 5Ј-CG GATGTGACACAAGAGA-3Ј.
Before development of the multiplex PCR, the EEE RT-PCR was evaluated. The procedure for ribonucleic acid (RNA) extraction and PCR cycling conditions were identical to those described for the WN RT-PCR. 3 The PCR product was analyzed by agar gel electrophoresis followed by ethidium bromide staining and ultraviolet visualization. A 140-bp product indicated EEE viral RNA was present in the original sample. Twenty-eight brain samples collected in 2001 and 2002 from horses and birds exhibiting clinical signs of encephalitis were used to evaluate the PCR procedure. Virus isolation testing indicated 18 samples were EEEpositive and 10 samples were EEE-negative. PCR amplification and viewing of the 140-bp EEE product occurred only with EEE-positive samples. No amplification occurred in the EEE-negative samples. Deoxyribonucleic acid (DNA) sequencing was performed on 10 of the EEE RT-PCR products originating from the eastern, southern, and Midwestern United States. Comparison of the amplified 140-bp region in the 10 samples showed 97%-100% homology with the published sequence of the North American EEE virus, derived from a 1982 Florida mosquito isolate. 7 The EEE RT-PCR was tested against the related alphaviruses western equine encephalomyelitis (WEE) virus (Fleming strain) and Venezuelan equine encephalomyelitis (VEE) virus (strains 1AB, 1C, 1D, 1E, 1F, and TC-83) as well as the WN virus and found to amplify only the EEE virus. No strains of the South American EEE virus were available for evaluation.
Parameters were determined for a nested mRT-PCR reaction using the WN primers and the North American EEE primers described above. 2, 5 Total RNA was extracted from 50-100 mg of brain tissue using Trizol reagent b according to the manufacturer's instructions. EEE and WN virus controls were prepared by extracting RNA from a 100-l volume containing 100 TCID 50 of each stock virus. Extracted samples were resuspended in 15 l of ribonuclease (RNase)-free water and denatured at 70 C for 10 minutes. Two microliters of each denatured RNA sample was added to 48 l of RT-PCR mixture with a final composition of 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 3.0 mM MgCl 2 , 0.8 mM deoxynucleoside triphosphate (dNTP) pool, 25 units Moloney Murine Leukemia Virus reverse transcriptase, b 1.25 units RNase inhibitor, b 1.25 units AmpliTaq Gold, c and 25 pmol each of the EEE and WN first-stage primers. Similarly, 2.0 l of RNase-free water was added to ''no-template'' controls that were interspersed among the samples for the detection of possible carryover contamination. Reaction tubes were incubated at 45 C for 45 minutes and 95 C for 11 minutes, followed by 35 cycles of 95 C denaturation for 30 seconds, 55 C primer annealing for 45 seconds, and 72 C extension for 60 seconds. The final cycle had a 5-minute extension time. For the nested reaction, 1.5 l of the first-stage amplification product was added to a tube containing 48.5 l of a PCR mixture with a final composition of 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 3.0 mM MgCl 2 , 0.8 mM dNTP pool, 1.25 units AmpliTaq Gold, and 25 pmol each of the EEE and WN nested primers. Reaction tubes were incubated for 11 minutes at 95 C, followed by 35 cycles of the cycling conditions described for the first stage. All incubation and amplification procedures were performed using a Perkin-Elmer 9600 PCR system. c RT-PCR products were analyzed by electrophoresis in 3% agarose, d followed by ethidium bromide staining and ultraviolet visualization. A 140-bp product indicated EEE viral RNA was present in the original sample. The presence of the WN virus was indicated by a 248-bp product (Fig. 1) .
The sensitivity of the assays was determined by side-by-side comparison of virus dilutions in Vero cell cultures, nested RT-PCR (EEE or WN), and EEE/WN nested mRT-PCR ( Fig. 2) . A 100-l volume of each 10-fold dilution of the EEE and WN viruses was tested in duplicate on each of the 3 tests. For the EEE virus, the end point dilution in cell culture was 10 Ϫ5.0 /100 l. detected 10 Ϫ7.5 /100 l. Neither the EEE virus nor the WN virus was detected beyond 10 Ϫ1 /100 l after the first stage of amplification with either PCR procedure.
To determine whether the multiplex assay was capable of detecting both the EEE virus and the WN virus in animals that may be infected with both viruses, RNA was extracted from 2 pools containing approximately 50 mg each of EEE-positive and WN-positive horse brain tissue. EEE and WN viral RNA were both detected in the pooled samples tested (data not shown).
Validation testing of the multiplex procedure was performed on 157 brain tissue samples collected from animals exhibiting symptoms of encephalitis. All sam-ples were tested by 3 Subsequent to the validation testing, the EEE/WN nested mRT-PCR procedure was performed on 485 brain tissue samples submitted to the NVSL in the summer and fall of 2002 (Table 2 ). These tissues had been collected from 425 horses and 60 other mammals and birds exhibiting clinical symptoms of encephalitis. A total of 255 animals were mRT-PCR-positive (8 EEE, 247 WN); no mixed infections of EEE and WN were detected. Of the 8 samples positive for EEE by mRT-PCR, five were confirmed by virus isolation, two samples were unsuitable for virus isolation, and EEE virus was not isolated from one sample and a serological sample was not available for confirmation. All the EEE-positive samples were from horses. Of the 247 brain tissues positive for WN by mRT-PCR, 89 were confirmed by virus isolation or the horse was serologically positive by MAC-ELISA. Virus isolation was unsuccessful on 85 PCR-positive samples with no serum or CSF available for confirmation testing. Brain tissues from 2 horses were mRT-PCR-positive for the WN virus; virus isolation and MAC-ELISA tests from those 2 horses were negative. Virus isolation procedures were not performed on 76 of the WN-positive samples. Because of increased demands on laboratory resources, the decision was made in October 2002 not to attempt virus isolation on WN mRT-PCR-positive samples originating from regions where WN virus infections were common. The majority (229) of the WNpositive samples were from horses; WN viral RNA was also detected in multiple mammalian and avian species. Two hundred thirty samples were negative by the EEE/WN mRT-PCR. Virus isolation tests were also negative for 198 of these samples. Virus isolation was not attempted on 32 of the negative samples. Serum or CSF was available for 33 of the mRT-PCRnegative horses, with 32 testing negative by MAC-ELISA. Serum from 1 mRT-PCR-negative horse was positive for WN by MAC-ELISA.
The multiplex assay described here amplifies and identifies the North American EEE and WN viruses directly from mammalian and avian brain tissues. The EEE primers do not amplify the related alphaviruses WEE and VEE. The specificity of the EEE primers was further demonstrated by sequencing 10 EEE PCRpositive reactions. The specificity of the WN PCR was previously described. 3 Taking the validation tests and the 2002 diagnostic tests together, of 32 samples positive for the EEE virus by mRT-PCR, 25 were confirmed by isolation or MAC-ELISA, 4 were unsuitable for isolation, and virus was not isolated from 3 samples. A total of 297 samples tested positive for WN viral RNA by mRT-PCR. One hundred thirty-three of these samples were confirmed by virus isolation or serological testing. Serological samples were not available for 161 of the WN-positive animals. It has been the authors' observation that isolation of WN virus from brain tissue of infected horses is often difficult. Interestingly, 3 horses testing positive for the WN virus by mRT-PCR were negative by MAC-ELISA. Possibly, these animals succumbed to virus infection soon after exposure to the virus before an immune response was present. Agreement between 280 negative EEE/ WN mRT-PCR and virus isolation tests further supports the specificity of the PCR assay in the identification of uninfected animals. Unfortunately, serological samples were available for only 44 of the negative samples. Forty-three negative mRT-PCR tests were supported by serological testing. However, 1 horse testing negative by mRT-PCR and virus isolation was serologically positive for WN by MAC-ELISA. It is likely that WN virus was not present in the brain region tested by mRT-PCR. Variability in virus load present in brain tissue of WN-infected horses has been previously reported. 1 It has been our experience that tissue collected from any region of the cerebellum, cerebrum, or spinal cord of a horse succumbing to WN or EEE virus infection will test positive by RT-PCR. However, in less than 1% of WN-infected horses, separate RNA samples extracted from different regions of the same brain will have both positive and negative results. Insufficient data are available for determination of brain regions most likely to harbor the WN virus.
End point dilution tests detected no loss of sensitivity in the multiplex reaction when compared with the individual EEE and WN nested RT-PCR assays. Detection of EEE virus using the EEE/WN nested mRT-PCR assay was 100-fold more sensitive than cell culture; the multiplex assay was 10,000-fold more sensitive than cell culture for the detection of the WN virus. The increased sensitivity of the nested multiplex assay was further supported by the fact that tissues from 1 serologically confirmed EEE-positive horse and 42 serologically confirmed WN-positive horses were positive by mRT-PCR; virus isolation attempts from the same 43 tissues were unsuccessful (data not shown). Comparison of EEE/WN nested mRT-PCR results with those from first-stage amplification showed the nested amplification to be 100,000-fold more sensitive. In the validation study, 12 (11 horse, 1 bird) of 24 EEE-positive brain samples and 12 (3 horse, 9 bird) of 50 WN-positive brain samples tested had sufficient amplification after the first-stage PCR to be viewed after ethidium bromide staining and ultraviolet illumination ( Fig. 3 ). Experience has shown that brain tissues from WN-infected horses often do not contain sufficient virus for WN detection by a single-stage PCR or for virus isolation in cell culture to be successful. Brain tissues from WN-infected birds apparently harbor a higher concentration of virus, and first stage PCR amplification is often sufficient for viral nucleic acid detection.
The multiplex PCR assay described here is useful for the rapid identification of North American EEE and WN viral RNA directly from brain tissues. Adherence to a strict PCR protocol is critical when performing all nested PCR procedures to avoid cross-contamination between samples. Confidence in the procedure may be increased by testing duplicate samples and including multiple controls.
